Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cryolife (NY: CRY )

24.24 USD -0.58 (-2.34%)
Official Closing Price Updated: 7:00 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Cryolife

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
CryoLife to Participate in Upcoming Investor Conferences
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming investor conferences. 
From PR Newswire
CryoLife Reports Second Quarter 2019 Financial Results
From PR Newswire
CryoLife to Present at Canaccord Genuity 39th Annual Growth Conference
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2019 Second Quarter Financial Results
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 second quarter financial results will be released on Tuesday, July 30,... 
From PR Newswire
CryoLife Reports First Quarter 2019 Financial Results
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2019 First Quarter Financial Results
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 first quarter financial results will be released on Tuesday, April 30,... 
From PR Newswire
Report: Exploring Fundamental Drivers Behind Franco-Nevada, ADMA Biologics, GSI Technology, CryoLife, Simpson Manufacturing, and Pioneer Power Solutions — New Horizons, Emerging Trends, and Upcoming D
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Franco-Nevada... 
From GlobeNewswire News Releases
CryoLife to Present at 18th Annual Needham Healthcare Conference
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 18th Annual Needham Healthcare Conference... 
From PR Newswire
CryoLife to Present at Cowen and Company 39th Annual Health Care Conference
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Cowen and Company 39th Annual Health Care... 
From PR Newswire
CryoLife Reports Fourth Quarter and Full Year 2018 Financial Results
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2018 Fourth Quarter and Year-end Financial Results
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2018 fourth quarter and year-end financial results will be released on... 
From PR Newswire
Recent Analysis Shows Brown Forman, CryoLife, Aspen Group, Taylor Devices, Synergy Pharmaceuticals, and Ramco-Gershenson Properties Trust Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Brown Forman Corporation... 
From GlobeNewswire News Releases
CryoLife Reports Third Quarter 2018 Results
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today its financial results for the third quarter ended September 30, 2018. 
From PR Newswire
CryoLife Reports Preliminary Financial Results for Third Quarter 2018 in Anticipation of Discussions with Senior Lenders Regarding Repricing Senior Credit Facility
Announces Release Date and Teleconference Call Details for 2018 Third Quarter Financial Results 
From PR Newswire
CryoLife to Present at Deutsche Bank 26th Annual Leveraged Finance Conference
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Deutsche Bank 26th Annual Leveraged... 
From PR Newswire
CryoLife Reports Second Quarter 2018 Results
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today its financial results for the second quarter ended June 30, 2018. 
From PR Newswire
CryoLife to Present at 38th Annual Canaccord Genuity Growth Conference
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 38th Annual Canaccord Genuity Growth... 
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2018 Second Quarter Financial Results
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2018 second quarter financial results will be released on Monday, August 6,... 
From PR Newswire
Marna Borgstrom Joins CryoLife Board of Directors
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, today announced the appointment of Marna Borgstrom to its Board of Directors effective... 
From PR Newswire
CryoLife Announces Peer Review Publication of On-X® Aortic Heart Valve PROACT Study
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, today announces the publication of our clinical study entitled "Anticoagulation and Antiplatelet... 
From PR Newswire
CryoLife Reports First Quarter 2018 Results
From PR Newswire
CryoLife to Present at Deutsche Bank 43rd Annual Health Care Conference
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in a fireside chat presentation at the upcoming Deutsche... 
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2018 First Quarter Financial Results
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2018 first quarter financial results will be released on Wednesday, May 2,... 
From PR Newswire
CryoLife to Present at 17th Annual Needham Healthcare Conference
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 17th Annual Needham Healthcare Conference... 
From PR Newswire
CryoLife Reports Fourth Quarter and Full Year 2017 Results
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2017 Fourth Quarter and Year-End Financial Results
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that 2017 fourth quarter and year-end financial results will... 
From PR Newswire
CryoLife Completes Acquisition of JOTEC
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it has completed its previously announced acquisition of... 
From PR Newswire
CryoLife Announces Enrollment of First Patients in BioGlue® Clinical Trial in China
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that enrollment has started in the Company's BioGlue clinical... 
From PR Newswire
CryoLife Reports Third Quarter 2017 Results
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2017 Third Quarter Financial Results
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that 2017 third quarter financial results will be released on... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.